Pinnacle Wealth Planning Services, Inc. Fennec Pharmaceuticals Inc. Transaction History
Pinnacle Wealth Planning Services, Inc.
- $4.39 Billion
- Q4 2024
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 15,388 shares of FENC stock, worth $102,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,388Holding current value
$102,330% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding FENC
# of Institutions
64Shares Held
14.7MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$27.1 Million0.71% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$16 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$15 Million11.1% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$7.9 Million0.0% of portfolio
-
Dg Capital Management, LLC New York, NY1.11MShares$7.41 Million2.94% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $173M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...